Charge-modified single chain antibody constructs of monoclonal antibody CC49: Generation, characterization, pharmacokinetics, and biodistribution analysis

Gabriela Pavlinkova, Guy Beresford, Barbara J M Booth, Surinder Kumar Batra, David Colcher

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

A novel strategy was developed in which an antibody scFv fragment of the monoclonal antibody (MAb) CC49 was modified by engineering DNA coding sequences to lower its isoelectric point. Negatively charged amino acids were added to the carboxy terminus of the CC49 V(H) region by adding nucleotide sequences in a polymerase chain reaction (PCR) amplification of the coding sequence of CC49 scFv. Two new DNA constructs coding for CC49 scFv with lower isoelectric points of 5.8 and 5.2 were engineered. These novel strategy- generated, charge-modified antibody constructs were compared for their immunological, pharmacokinetic, and biodistribution properties in athymic mice bearing LS-174T human colon carcinoma xenografts.

Original languageEnglish (US)
Pages (from-to)27-34
Number of pages8
JournalNuclear Medicine and Biology
Volume26
Issue number1
DOIs
StatePublished - Jan 1 1999

Fingerprint

Single-Chain Antibodies
Isoelectric Point
Pharmacokinetics
Monoclonal Antibodies
Immunoglobulin Fragments
Heterografts
Nude Mice
Colon
Carcinoma
Amino Acids
Polymerase Chain Reaction
Antibodies
DNA

Keywords

  • Antibody engineering
  • Colon carcinoma xenografts
  • Isoelectric point
  • Radioimmunodiagnosis
  • Single chain fragments

ASJC Scopus subject areas

  • Molecular Medicine
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Charge-modified single chain antibody constructs of monoclonal antibody CC49 : Generation, characterization, pharmacokinetics, and biodistribution analysis. / Pavlinkova, Gabriela; Beresford, Guy; Booth, Barbara J M; Batra, Surinder Kumar; Colcher, David.

In: Nuclear Medicine and Biology, Vol. 26, No. 1, 01.01.1999, p. 27-34.

Research output: Contribution to journalArticle

@article{1660ad9af662406ea7791a487c1a9616,
title = "Charge-modified single chain antibody constructs of monoclonal antibody CC49: Generation, characterization, pharmacokinetics, and biodistribution analysis",
abstract = "A novel strategy was developed in which an antibody scFv fragment of the monoclonal antibody (MAb) CC49 was modified by engineering DNA coding sequences to lower its isoelectric point. Negatively charged amino acids were added to the carboxy terminus of the CC49 V(H) region by adding nucleotide sequences in a polymerase chain reaction (PCR) amplification of the coding sequence of CC49 scFv. Two new DNA constructs coding for CC49 scFv with lower isoelectric points of 5.8 and 5.2 were engineered. These novel strategy- generated, charge-modified antibody constructs were compared for their immunological, pharmacokinetic, and biodistribution properties in athymic mice bearing LS-174T human colon carcinoma xenografts.",
keywords = "Antibody engineering, Colon carcinoma xenografts, Isoelectric point, Radioimmunodiagnosis, Single chain fragments",
author = "Gabriela Pavlinkova and Guy Beresford and Booth, {Barbara J M} and Batra, {Surinder Kumar} and David Colcher",
year = "1999",
month = "1",
day = "1",
doi = "10.1016/S0969-8051(98)00075-4",
language = "English (US)",
volume = "26",
pages = "27--34",
journal = "International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology",
issn = "0969-8051",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Charge-modified single chain antibody constructs of monoclonal antibody CC49

T2 - Generation, characterization, pharmacokinetics, and biodistribution analysis

AU - Pavlinkova, Gabriela

AU - Beresford, Guy

AU - Booth, Barbara J M

AU - Batra, Surinder Kumar

AU - Colcher, David

PY - 1999/1/1

Y1 - 1999/1/1

N2 - A novel strategy was developed in which an antibody scFv fragment of the monoclonal antibody (MAb) CC49 was modified by engineering DNA coding sequences to lower its isoelectric point. Negatively charged amino acids were added to the carboxy terminus of the CC49 V(H) region by adding nucleotide sequences in a polymerase chain reaction (PCR) amplification of the coding sequence of CC49 scFv. Two new DNA constructs coding for CC49 scFv with lower isoelectric points of 5.8 and 5.2 were engineered. These novel strategy- generated, charge-modified antibody constructs were compared for their immunological, pharmacokinetic, and biodistribution properties in athymic mice bearing LS-174T human colon carcinoma xenografts.

AB - A novel strategy was developed in which an antibody scFv fragment of the monoclonal antibody (MAb) CC49 was modified by engineering DNA coding sequences to lower its isoelectric point. Negatively charged amino acids were added to the carboxy terminus of the CC49 V(H) region by adding nucleotide sequences in a polymerase chain reaction (PCR) amplification of the coding sequence of CC49 scFv. Two new DNA constructs coding for CC49 scFv with lower isoelectric points of 5.8 and 5.2 were engineered. These novel strategy- generated, charge-modified antibody constructs were compared for their immunological, pharmacokinetic, and biodistribution properties in athymic mice bearing LS-174T human colon carcinoma xenografts.

KW - Antibody engineering

KW - Colon carcinoma xenografts

KW - Isoelectric point

KW - Radioimmunodiagnosis

KW - Single chain fragments

UR - http://www.scopus.com/inward/record.url?scp=0032891911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032891911&partnerID=8YFLogxK

U2 - 10.1016/S0969-8051(98)00075-4

DO - 10.1016/S0969-8051(98)00075-4

M3 - Article

C2 - 10096498

AN - SCOPUS:0032891911

VL - 26

SP - 27

EP - 34

JO - International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology

JF - International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology

SN - 0969-8051

IS - 1

ER -